// company-profile

Maze Therapeutics, Inc.

MAZE
ExchangeNasdaqSectorBiological Products, (No Diagnostic Substances)Inc.DEFilings61Insiders22
// api This Maze Therapeutics, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.

// activity-summary

Recent insider activity is bullish. Over the last 30 days, 6 insiders purchased shares. Buying was led by Hoppenot Herve.

// 90-day insight

Over the last 90 days, Maze Therapeutics, Inc. insiders bought $149K across 11 transactions with no open-market sales.

  • Most active insider: Dandekar Atul with 14 transactions totaling $991K.
  • Largest single sale: $666K by Coloma Jason V on May 26, 2026.
  • 100% of recent sales were pre-scheduled 10b5-1 trades — typically less informative than open-market activity.

Activity skews bullish — buys outpace sales.

Institutional Ownership

Top 13F-HR holders of Maze Therapeutics, Inc. as of 2026-03-31

↓ decreasing
Total reported AUM
$1.53B
QoQ change
-19.0%
Reporting period
2026-03-31
#1
Frazier Life Sciences Management, L.P.
CIK 1892134
$136.3M
4.6M shares
#2
TRV GP IV, LLC
CIK 1688325
$133.5M
4.5M shares
#3
ARCH Venture Management, LLC
CIK 1274403
$123.0M
4.1M shares

Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Jun 8, 2026Hoppenot HerveMAZE
Award
18,000$0.00$0K
Jun 8, 2026SCHELLER RICHARD HMAZE
Award
18,000$0.00$0K
Jun 8, 2026Andrews Nancy CMAZE
Award
18,000$0.00$0K
Jun 8, 2026Lim Jonathan EMAZE
Award
18,000$0.00$0K
Jun 8, 2026SPIEGELMAN DANIEL KMAZE
Award
18,000$0.00$0K

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.